SCP: Lupin acquires Southern Cross Pharma in Australia; Stock rises 1.5%
This will significantly increase Lupins value proposition and market share in the Australian market.
Read full article »
Managing Director
Neill Stacey
SCP is an Australia-based company that researches and develops prescription medicinal products for retail pharmacy and healthcare sectors.
Read more